Sales Growth YoY (Last Twelve Months): Madrigal Corp (MDGL)

Graphic logo of Madrigal Pharmaceuticals (MDGL)

Leveraging its authority in treating liver pathologies, Madrigal Pharmaceuticals (MDGL) is demonstrating growth. The year-over-year sales volume increase over the last 12 months visualizes product demand, while the 93.30 metric indicates the status of current dynamics. This confirms the successful commercialization of NASH therapy and the completion of the R&D phase with the market launch of the flagship drug Rezdiffra.

Sales Growth YoY (Last Twelve Months): Madrigal Pharma (MDGL) for 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for Madrigal Pharmaceuticals Inc (MDGL)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:MDGL (Madrigal Pharma)
Mass-produced product of Madrigal Pharmaceuticals, Inc.

This indicator measures operating revenue dynamics over the last 12 months relative to the same period last year, allowing investors to assess the pace of business scaling. Analyzing the rolling 12-month YoY revenue growth chart reveals how the commercialization of the first-in-class steatohepatitis therapy is transforming Madrigal Pharmaceuticals (MDGL) from a development stage into an active profit generation stage.

Who Madrigal Pharmaceuticals competes with

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|CORT - Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (Last Twelve Months)|AKRO: Sales Growth YoY (TTM)|MTSR - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) MoonLake Corp|Crinetics Corp (CRNX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) newamsterdampharma.com (NAMS)|Revenue Growth YoY (Last 12 Months) soleno.life SLNO|Sales Growth YoY (TTM) FOLD (amicusrx.com)|Annual Revenue Growth (Last Twelve Months) 89bio (ETNB)|Agios - Sales Growth YoY (TTM)|Structure Corp - Revenue Change YoY (Last 12 Months)|mimedx.com (MDXG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)